These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23373008)

  • 1. Formulation and evaluation of sublingual tablets containing Sumatriptan succinate.
    Prajapati ST; Patel PB; Patel CN
    Int J Pharm Investig; 2012 Jul; 2(3):162-8. PubMed ID: 23373008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and optimization of orally disintegrating tablets of sumatriptan succinate.
    Sheshala R; Khan N; Darwis Y
    Chem Pharm Bull (Tokyo); 2011; 59(8):920-8. PubMed ID: 21804234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taste Masked Orodispersible Formulation of Fexofenadine Hydrochloride Using Ion Exchange Resins.
    Suares D; Hiray A
    Indian J Pharm Sci; 2015; 77(5):550-5. PubMed ID: 26798169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and evaluation of artemether taste masked rapid disintegrating tablets with improved dissolution using solid dispersion technique.
    Shah PP; Mashru RC
    AAPS PharmSciTech; 2008; 9(2):494-500. PubMed ID: 18431657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
    Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Study Between Different Ready-Made Orally Disintegrating Platforms for the Formulation of Sumatriptan Succinate Sublingual Tablets.
    Tayel SA; El Nabarawi MA; Amin MM; AbouGhaly MH
    AAPS PharmSciTech; 2017 Feb; 18(2):410-423. PubMed ID: 27038484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast Disintegrating Combination Tablet of Taste Masked Levocetrizine Dihydrochloride and Montelukast Sodium: Formulation Design, Development, and Characterization.
    Gupta MM; Gupta N; Chauhan BS; Pandey S
    J Pharm (Cairo); 2014; 2014():568320. PubMed ID: 26556198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and evaluation of taste-masked levocetirizine dihydrochloride orally disintegrating tablets.
    Devireddy SR; Gonugunta CS; Veerareddy PR
    PDA J Pharm Sci Technol; 2009; 63(6):521-6. PubMed ID: 20169858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel levocetirizine HCl tablets with enhanced palatability: synergistic effect of combining taste modifiers and effervescence technique.
    Labib GS
    Drug Des Devel Ther; 2015; 9():5135-46. PubMed ID: 26379426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and characterization of patient-friendly dosage form of ondansetron hydrochloride.
    Bhoyar P; Biyani D; Umekar M
    J Young Pharm; 2010 Jul; 2(3):240-6. PubMed ID: 21042478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of sublingual tablets of zolmitriptan.
    Prajapati ST; Patel MV; Patel CN
    Int J Pharm Investig; 2014 Jan; 4(1):27-31. PubMed ID: 24678459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets.
    Khan S; Kataria P; Nakhat P; Yeole P
    AAPS PharmSciTech; 2007 Jun; 8(2):Article 46. PubMed ID: 17622121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants.
    Sheshala R; Khan N; Chitneni M; Darwis Y
    Arch Pharm Res; 2011 Nov; 34(11):1945-56. PubMed ID: 22139694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meloxicam taste-masked oral disintegrating tablet with dissolution enhanced by ion exchange resins and cyclodextrin.
    Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
    AAPS PharmSciTech; 2013 Sep; 14(3):1118-28. PubMed ID: 23835739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of taste-masked dextromethorphan oral disintegrating tablet.
    Samprasit W; Opanasopit P; Akkaramongkolporn P; Ngawhirunpat T; Wongsermsin K; Panomsuk S
    Pharm Dev Technol; 2012; 17(3):315-20. PubMed ID: 21142821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression.
    Tafere C; Yilma Z; Abrha S; Yehualaw A
    PLoS One; 2021; 16(3):e0246648. PubMed ID: 33725014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and evaluation of primaquine phosphate taste-masked rapidly disintegrating tablet.
    Shah PP; Mashru RC
    J Pharm Pharmacol; 2008 Oct; 60(10):1279-85. PubMed ID: 18812020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and development of taste masked fast-disintegrating tablets (FDTs) of Chlorpheniramine maleate using ion-exchange resins.
    Yewale CP; Rathi MN; Kore GG; Jadhav GV; Wagh MP
    Pharm Dev Technol; 2013; 18(2):367-76. PubMed ID: 22023351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
    Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
    Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation development, in vivo bioequivalence and pediatric PBPK modeling studies of taste-masked ciprofloxacin chewable tablets.
    Usmani MT; Shoaib MH; Siddiqui F; Ahmed FR; Yousuf RI; Saleem MT
    Sci Rep; 2023 Sep; 13(1):16070. PubMed ID: 37752265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.